Return Health

Return Health is developing novel psychedelic compounds for treating people with dementia. The company are utilizing AI technology to accelerate the drug discovery process.

Return Health

On July 19th 2021, Return Health raised U$3.5 million in a Seed round of funding.

“Return Health is developing novel psychedelic therapeutics for dementia that fundamentally alter disease progression — reducing behavioural and psychological symptoms, reversing cognitive decline, and ultimately improving quality of life for patients and their caregivers”